Center-Authored Papers

Filters: Author is Poniewierski, Marek S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Young Adult
Ferro SA, Myer BS, Wolff DA, Poniewierski MS, Culakova E, Cosler LE, Scarpace SL, Khorana AA, Lyman GH.  2008.  Variation in the cost of medications for the treatment of colorectal cancer.. The American journal of managed care. 14(11):717-25. Abstract
United States
Griggs JJ, Culakova E, Sorbero MES, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.  2007.  Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(18):2522-7. Abstract
Griggs JJ, Culakova E, Sorbero MES, van Ryn M, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.  2007.  Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(3):277-84. Abstract
Crawford J, Dale DC, Kuderer NM, Culakova E, Poniewierski MS, Wolff D, Lyman GH.  2008.  Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(2):109-18. Abstract
Treatment Outcome
Lyman GH, Dale DC, Wolff DA, Culakova E, Poniewierski MS, Kuderer NM, Crawford J.  2010.  Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(17):2914-24. Abstract
Griggs JJ, Culakova E, Sorbero MES, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.  2007.  Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(18):2522-7. Abstract
Thrombocytopenia
Shayne M, Culakova E, Wolff D, Poniewierski MS, Dale DC, Crawford J, Lyman GH.  2009.  Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy.. Cancer. 115(22):5319-28. Abstract
Survival Analysis
Griggs JJ, Culakova E, Sorbero MES, van Ryn M, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.  2007.  Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(3):277-84. Abstract
Social Class
Griggs JJ, Culakova E, Sorbero MES, van Ryn M, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.  2007.  Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(3):277-84. Abstract
Severity of Illness Index
Shayne M, Culakova E, Poniewierski MS, Wolff D, Dale DC, Crawford J, Lyman GH.  2007.  Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy.. Cancer. 110(7):1611-20. Abstract
Risk Factors
Crawford J, Dale DC, Kuderer NM, Culakova E, Poniewierski MS, Wolff D, Lyman GH.  2008.  Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(2):109-18. Abstract
Laskey RA, Poniewierski MS, Lopez MA, Hanna RK, Secord AA, Gehrig PA, Lyman GH, Havrilesky LJ.  2012.  Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer.. Gynecologic oncology. 125(3):625-30. Abstract
Griggs JJ, Culakova E, Sorbero MES, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.  2007.  Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(18):2522-7. Abstract
Wolff D, Culakova E, Poniewierski MS, Lyman GH, Dale DC, Crawford J.  2005.  Predictors of chemotherapy-induced neutropenia and its complications: results from a prospective nationwide registry.. The journal of supportive oncology. 3(6 Suppl 4):24-5.
Risk Assessment
Wolff D, Culakova E, Poniewierski MS, Lyman GH, Dale DC, Crawford J.  2005.  Predictors of chemotherapy-induced neutropenia and its complications: results from a prospective nationwide registry.. The journal of supportive oncology. 3(6 Suppl 4):24-5.
Lyman GH, Kuderer NM, Crawford J, Wolff DA, Culakova E, Poniewierski MS, Dale DC.  2011.  Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy.. Cancer. 117(9):1917-27. Abstract
Retrospective Studies
Hanna RK, Poniewierski MS, Laskey RA, Lopez MA, Shafer A, Van Le L, Crawford J, Dale DC, Gehrig PA, Secord AA et al..  2013.  Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer.. Gynecologic oncology. 129(1):74-80. Abstract
Laskey RA, Poniewierski MS, Lopez MA, Hanna RK, Secord AA, Gehrig PA, Lyman GH, Havrilesky LJ.  2012.  Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer.. Gynecologic oncology. 125(3):625-30. Abstract
Reproducibility of Results
Lyman GH, Kuderer NM, Crawford J, Wolff DA, Culakova E, Poniewierski MS, Dale DC.  2011.  Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy.. Cancer. 117(9):1917-27. Abstract
Registries
Griggs JJ, Culakova E, Sorbero MES, van Ryn M, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.  2007.  Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(3):277-84. Abstract
Wolff D, Culakova E, Poniewierski MS, Lyman GH, Dale DC, Crawford J.  2005.  Predictors of chemotherapy-induced neutropenia and its complications: results from a prospective nationwide registry.. The journal of supportive oncology. 3(6 Suppl 4):24-5.
Crawford J, Dale DC, Kuderer NM, Culakova E, Poniewierski MS, Wolff D, Lyman GH.  2008.  Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(2):109-18. Abstract
Randomized Controlled Trials as Topic
Lyman GH, Dale DC, Wolff DA, Culakova E, Poniewierski MS, Kuderer NM, Crawford J.  2010.  Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(17):2914-24. Abstract
Public Health Sciences Division
Culakova E, Thota R, Poniewierski MS, Kuderer NM, Wogu AF, Dale DC, Crawford J, Lyman GH.  2014.  Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study.. Cancer medicine. 3(2):434-44. Abstract
Prospective Studies
Griggs JJ, Culakova E, Sorbero MES, van Ryn M, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.  2007.  Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(3):277-84. Abstract